Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Acorda Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 30 | −5 |
| Shares | 5.36M | 132.5K | 6.50M | +1.28M (+24.4%) |
| Value | $4.09M | $102.0K | $3.71M | −$280.2K (−7.0%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Acorda Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Davidson Kempner Partners | 1,803,070 | $1.01M | 0.03% |
| HRT Financial LP | 12,520 | $7.00K | 0.00% |
Sold out (7)
Institutions that held Acorda Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Prudential Financial Inc | 31,400 | $24.1K |
| United Asset Strategies, Inc. | 27,100 | $20.8K |
| Verition Fund Management LLC | 13,641 | $10.5K |
| Citigroup Inc | 355 | $272 |
| IMA Wealth, Inc. | 17 | $13 |
| JNBA Financial Advisors | 1 | $1 |
| Rockefeller Capital Management L.P. | 167 | $0 |
Not filed for Q1 2023 yet (1)
Institutions that held Acorda Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Telemetry Investments, L.L.C. | 132,500 | $102.0K |